Rare Disease Project in Russia
A multi-center rare disease Phase 3b clinical trial has been awarded to GCT.
February 27, 2019
Database Locked for the Women’s Health Study
The database for the Phase III Women’s Health Study was locked on February 4th after 7 years of trial duration.
This is a multi-center, randomized, double-blind study conducted in patients with a previous preterm delivery, for its further prevention..
February 8, 2019
Phase-III Ophthalmic Study is Approved within 44 Working Days
The end of the year was marked for GCT team with yet another achievement.
Clinical trial approval was received ahead of official timelines for Phase III study,
– the whole review process, including Q/A with competent authority, lasted 44 working days.
January 10, 2019
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Tel Aviv, Israel
2019, May 14-16
Mercure Kyiv Congress Centre
2019, May 16—17
San Francisco, California, USA
2019, May 18 — 22
Hotel St. Petersburg
St. Petersburg, Russia
2019, May 27 — 31